MTOR and neoplasm: The irradiation conditions involve the exposure to C-ion beams; the treatment also included miRNA-34, a tumor suppressor miRNA that targets multiple oncogenic pathways, and rapamycin, an mTOR inhibitor, which is used to disrupt the mTOR signaling pathway commonly upregulated in cancer cells.